<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-09-16 - UAE grants emer&#xAD;gency ap&#xAD;proval for China vac&#xAD;cine</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200916/281784221513003" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>UAE grants emer&#xAD;gency ap&#xAD;proval for China vac&#xAD;cine</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200916/textview" title="The Straits Times - 2020-09-16"><time>2020-09-16</time></a>
        - <span>WORLD</span>
        - <span role="byline"></span>
    </section>

    <p>DUBAI • The United Arab Emi­rates (UAE) has granted emer­gency ap­proval for use of a coro­n­avirus vac­cine, six weeks after hu­man tri­als in the Gulf Arab state started.</p>
    <p>A Phase III trial of a Covid-19 in­ac­ti­vated vac­cine de­vel­oped by Chi­nese state-owned phar­ma­ceu­ti­cal com­pany Sinopharm be­gan in the UAE in July.</p>
    <p>“The vac­cine will be avail­able to our first line of de­fence he­roes who are at the high­est risk of con­tract­ing the virus,” said the Na­tional Emer­gency Crisis and Dis­as­ter Man­age­ment Au­thor­ity in a tweet.</p>
    <p>The an­nounce­ment comes amid a surge in new Covid-19 cases in the UAE, which re­ported 1,007 cases last Satur­day, its high­est since the start of the pan­demic. There were 777 new cases on Mon­day.</p>
    <p>Emer­gency use of the vac­cine, which is still be­ing tested, was granted un­der set cri­te­ria and after it had been tested on 31,000 vol­un­teers, it said.</p>
    <p>Mild and ex­pected side ef­fects oc­curred but there have been no se­vere side ef­fects, the agency said with­out spec­i­fy­ing. It added that 1,000 peo­ple suf­fer­ing from chronic dis­eases who took part saw no com­pli­ca­tions.</p>
    <p>Sinopharm se­cured ap­proval for the trial in late June. The ex­per­i­men­tal vac­cine passed Phases I and II of clin­i­cal tri­als with 100 per cent of vol­un­teers gen­er­at­ing an­ti­bod­ies after two doses in 28 days, an Abu Dhabi gov­ern­ment state­ment said in July.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
